ID
33729
Description
A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01682902
Link
https://clinicaltrials.gov/show/NCT01682902
Keywords
Versions (1)
- 12/21/18 12/21/18 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
December 21, 2018
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes NCT01682902
Eligibility Diabetes NCT01682902
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Diabetic Ketoacidosis Episodes Hospitalization Required
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0011880
- UMLS CUI [1,2]
- C0332189
- UMLS CUI [1,3]
- C1708385
Description
Infusion site abscess
Data type
boolean
Alias
- UMLS CUI [1]
- C1142012
Description
Loss of hypoglycemic warning | Hypoglycaemic episodes Severe Hospitalization Required
Data type
boolean
Alias
- UMLS CUI [1]
- C0342317
- UMLS CUI [2,1]
- C0745153
- UMLS CUI [2,2]
- C0205082
- UMLS CUI [2,3]
- C1708385
Similar models
Eligibility Diabetes NCT01682902
- StudyEvent: Eligibility
C0872146 (UMLS CUI [1,2])
C0393124 (UMLS CUI [2])
C0205369 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,2])
C1708385 (UMLS CUI [1,3])
C0745153 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C1708385 (UMLS CUI [2,3])